Tie, a novel endothelial cell receptor tyrosine kinase
CA 2127540 A1 · Owner: Makela, Tomi P. · Inventors: Armstrong, Elina; Partanen, Juha; Alitalo, Kari
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The cloning sequencing and expression of a novel receptor tyrosine kinase, termed tie, is described. The tie precursor comprises 1138 amino acid residues, about 1117 residues of which comprise the mature tie. The tie extracellular domain contains distinct stretches of amino acid sequence having features of the imunoglobulin, epidermal growth factor and fibronectin type III repeat protein families. Alternative splicing creates variants of tie which lack one of the epidermal growth factor homology domains. A specific tyrosine phosphorylated 117 kD glycoprotein is detected by specific tie-antisera from cultured cells expressing the tie gene. The tie mRNA is expressed in cultured endothelial …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 8, 1993. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 8, 2013.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 8, 2015.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.